Function & Application:

Marbofloxacin is a fluoroquinolone antibacterial drug used to treat deep and superficial skin infections, urinary tract infections in dogs, skin and soft tissue infections in cats, and acute upper respiratory infections.

Used for respiratory tract, digestive tract, urinary tract and skin infections of cattle, pigs, dogs and cats caused by sensitive bacteria. It is also effective for bovine and goat mastitis and swine mastitis-metritis-agalactia syndrome.

Withdrawal period: 6 days for cattle, 1.5 days for milk abandonment period; 2 days for pigs.

Marbofloxacin can be used both orally and topically. It is particularly used for infections of the skin, respiratory system and mammary glands, as well as with urinary tract infections in dogs and cats. For dogs, a dose of approximately 2 mg/kg is used. The duration of treatment is usually at least five days, longer if there is a concurrent fungal or yeast infection.
 Malbofloxacin is a novel fluoroquinolone antibacterial agent that inhibits the growth of bacteria by inhibiting bacterial DNA transcriptase and has antibacterial effects against Gram-negative bacteria, Gram-positive bacteria and mycoplasma. Malborfloxacin is well absorbed by both oral and injectable drugs with low toxic and side effects.
Fluoroquinolones are used to treat deep and superficial skin infections in dogs, urinary tract infections, cat skin and soft tissue infections, and acute upper respiratory tract infections.
It is used for the infection of respiratory tracts, digestive tracts, urinary tracts and skin caused by susceptible bacteria in cattle, pigs, dogs and cats. It is also effective for cattle, sheep mastitis, and swine mastitis-myometitis-agalactia syndrome.